The effects of Urtica dioica L. ethanolic extract against urinary calculi in rats

Abstract

Nephrolithiasis is common urological problem and stone formation has multiple underlying pathogenetic factors. We investigated the possible preventive and therapeutic effects of Urtica dioica ethanol extract (UD) on ethylene glycol-induced nephrolithiasis model in rats. Sprague-Dawley rats were divided into four groups (n = 10). The control group was given normal drinking water for 8 weeks and was administered vehicle by gastric gavage. Stone formation was induced by adding 0.75% ethylene glycol (EG) to their drinking water. UD (700 mg/kg) was given orally for 8 weeks to the preventive group and for last 4 weeks to the treatment group, respectively. At the end of the experiment, urine, blood samples and kidney tissues were obtained. In 24-hour urine samples, calcium and citrate levels were decreased and oxalate levels were increased in EG group whereas UD treatment groups reversed these parameters back to control levels. In addition, serum levels of creatinine and urea were increased in EG group, while UD significantly reduced these parameters. Malondialdehyde, 8-hydroxydeoxyguanosine and tumor necrosis alpha levels, and caspase-3 and N-acetyl-β-glucosaminidase activities were elevated in EG group and showed a decrease in UD treated groups. Glutathione level was decreased in EG group, whereas it was increased in UD preventive group. Histological examination showed an improvement in UD treated groups. Our results suggest that UD is effective both in prevention and treatment for kidney stones. The mechanism underlying this effect may be the antioxidant effect of UD and the effect on the concentration of stone-forming components in the urine.

Keywords

• Urtica dioica
• kidney stone
• calcium oxalate
• urolithiasis
• antioxidant

References

1. [1] Alelign T, Petros B. Kidney Stone Disease: An Update on Current Concepts. Adv Urol. 2018; 2018: 3068365. [CrossRef]
2. [2] Shah O, Assimos DG, Holmes RP. Genetic and dietary factors in urinary citrate excretion. J Endourol. 2005; 19: 177-182. [CrossRef]
3. [3] Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008; 17: 304-9. [CrossRef]
4. [4] Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG. Kidney stones. Nat Rev Dis Primers. 2016; 25: 16008. [CrossRef]
5. [5] Yousefi Ghale-Salimi M, Eidi M, Ghaemi N, Khavari-Nejad RA. Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: in vitro study. Ren Fail. 2018; 40(1): 298-305. [CrossRef]
6. [6] Agawane SB, Gupta VS, Kulkarni MJ, Bhattacharya AK, Koratkar SS, Rao VK. Patho-physiological evaluation of Duranta erecta for the treatment of urolithiasis. J Ayurveda Integr Med. 2019; 10(1): 4-11. [CrossRef]
7. [7] Emamiyan MZ, Vaezi G, Tehranipour M, Shahrohkabadi K, Shiravi A. Preventive effects of the aqueous extract of Cichorium intybus L. flower on ethylene glycol-induced renal calculi in rats. Avicenna J Phytomed. 2018; 8(2): 170-178.
8. [8] Nirumand MC, Hajialyani M, Rahimi R, Farzaei MH, Zingue S, Nabavi SM, Bishayee A. Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms. Int J Mol Sci. 2018; 19(3): 765. [CrossRef]

9. [9] Güner A, Türkiye Bitkileri Listesi (Damarlı bitkiler), firsth ed., Nezahat Gökyiǧit Botanik Bahçesi Yayınları, Istanbul, Turkey 2012.
10. [10] Joshi BC, Mukhija M, Kalia AN. Pharmacognostical review of Urtica dioica L. Int J Green Pharmacy. 2014; 8(4): 201-209.
11. [11] Salih NA. Effect of nettle (Urtica dioica) extract on gentamicin induced nephrotoxicity in male rabbits. Asian Pac J Trop Biomed. 2015; 5(9): 756–760. [CrossRef]
12. [12] Zhang H, Li N, Li K, Li P. Protective effect of Urtica dioica methanol extract against experimentally induced urinary calculi in rats. Mol Med Rep. 2014; 10(6): 3157-3162. [CrossRef]
13. [13] Karadi RV, Gadge NB, Alagawadi KR, Savadi RV. Effect of Moringa oleifera Lam. root-wood on ethylene glycol induced urolithiasis in rats. J Ethnopharmacol. 2006; 105(1-2): 306-311. [CrossRef]
14. [14] Lin WC, Lai MT, Chen HY, Ho CY, Man KM, Shen JL, Lee YJ, Tsai FJ, Chen YH, Chen WC. Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats. Urol Res. 2012; 40(6): 655-661. [CrossRef]
15. [15] Gupta S, Kanwar SS. Phyto-molecules for Kidney Stones Treatment and Management. Anal Biochem. 2018; 7: 4. [CrossRef]
16. [16] Mekhfi H, El Haouari M, Legssyer A, Bnouham M, Aziz M, Atmani F, Remmal A, Ziyyat A. Platelet anti-aggregant property of some Moroccan medicinal plants. J Ethnopharmacol. 2004; 94(2-3): 317-322. [CrossRef]
17. [17] Vogl S, Picker P, Mihaly-Bison J, Fakhrudin N, Atanasov AG, Heiss EH, Wawrosch C, Reznicek G, Dirsch VM, Saukel J, Kopp B. Ethnopharmacological in vitro studies on Austria's folk medicine--an unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs. J Ethnopharmacol. 2013; 149(3): 750-771. [CrossRef]
18. [18] Kadan S, Saad B, Sasson Y, Zaid H. In Vitro Evaluations of Cytotoxicity of Eight Antidiabetic Medicinal Plants and Their Effect on GLUT4 Translocation. Evid Based Complement Alternat Med. 2013; 2013: 549345. [CrossRef]
19. [19] Patel SS, Udayabanu M. Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice. Metab Brain Dis. 2014; 29(1): 121-130. [CrossRef]
20. [20] Khan SR. Animal models of kidney stone formation: an analysis. World J Urol. 1997; 15: 236e43 [CrossRef]
21. [21] Bouanani S, Henchiri C, Migianu-Griffoni E, Aouf N, Lecouvey M. Pharmacological and toxicological effects of Paronychia argentea in experimental calcium oxalate nephrolithiasis in rats. J Ethnopharmacol. 2010; 129(1):38-45. [CrossRef]
22. [22] El Menyiy N, Al Waili N, Bakour M, Al-Waili H, Lyoussi B. Protective Effect of Propolis in Proteinuria, Crystaluria, Nephrotoxicity and Hepatotoxicity Induced by Ethylene Glycol Ingestion. Arch Med Res. 2016; 47(7): 526-534. [CrossRef]
23. [23] Ashok P, Koti BC, Vishwanathswamy AH. Antiurolithiatic and antioxidant activity of Mimusops elengi on ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol. 2010; 42(6): 380-383. [CrossRef]
24. [24] Tugcu V1, Kemahli E, Ozbek E, Arinci YV, Uhri M, Erturkuner P, Metin G, Seckin I, Karaca C, Ipekoglu N, Altug T, Cekmen MB, Tasci AI. Protective effect of a potent antioxidant, potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol. 2008; 22: 2723-2731. [CrossRef]
25. [25] Tunçdemir M, Demirkesen O, Oztürk M, Atukeren P, Gümüştaş MK, Turan T. Antiapoptotic effect of angiotensin-II type-1 receptor blockade in renal tubular cells of hyperoxaluric rats. Urol Res. 2010; 38(2): 71-80. [CrossRef]
26. [26] Zhai W, Zheng J, Yao X, Peng B, Liu M, Huang J, Wang G, Xu Y. Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat. BMC Complement Altern Med. 2013; 13: 228. [CrossRef]
27. [27] Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014; 3(3): 256-276. [CrossRef]
28. [28] Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P. Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res. 2007; 35(4): 185-191. [CrossRef]
29. [29] Joshi S, Wang W, Khan SR. Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition. PLoS One. 2017; 12(11): e0185009. [CrossRef]
30. [30] Chen W, Liu WR, Hou JB, Ding JR, Peng ZJ, Gao SY, Dong X, Ma JH, Lin QS, Lu JR, Guo ZY. Metabolomic analysis reveals a protective effect of Fu-Fang-Jin-Qian-Chao herbal granules on oxalate-induced kidney injury. Biosci Rep. 2019; 22; 39(2). [CrossRef]
31. [31] Sayhan MB, Kanter M, Oguz S, Erboga M. Protective effect of Urtica dioica L. on renal ischemia/reperfusion injury in rat. J Mol Histol. 2012; 43(6): 691-698. [CrossRef]
32. [32] Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int. 2011; 80: 1278–1291. [CrossRef]
33. [33] Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW. Relative effect of urinary calcium and oxalate on saturation of calcium oxalate Rapid Communication. Kidney Int. 2004; 66(5): 2032-2037. [CrossRef]
34. [34] Asplin J, DeGanello S, Nakagawa YN, Coe FL. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol. 1991; 261(5 Pt 2): F824-30. [CrossRef]
35. [35] Macneil F, Bariol S. Urinary stone disease- assessment and management. Aust Fam Physician. 2011; 40(10): 772-775.
36. [36] Gauer S, Urbschat A, Gretz N, Hoffmann SC, Kränzlin B, Geiger H, Obermüller N. Kidney Injury Molecule-1 Is Specifically Expressed in Cystically-Transformed Proximal Tubules of the PKD/Mhm (cy/+) Rat Model of Polycystic Kidney Disease. Int J Mol Sci. 2016; 17(6). pii: E802. [CrossRef]
37. [37] Vaidya VS1, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol. 2006; 290(2): F517-29. [CrossRef]
38. [38] Mohamaden W, Wang H, Guan H, Meng X, Li J. Immunohistochemical localization and mRNA quantification of osteopontin and Tamm-Horsfall protein in canine renal tissue after potassium oxalate injection. BMC Vet Res. 2014; 17; 10: 70. [CrossRef]
39. [39] Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S. Expression of Osteopontin Messenger RNA by Macrophages in Atherosclerotic Plaques, A Possible Association with Calcification. Am J Pathol. 1993; 143(4):1003-1008. [CrossRef]
40. [40] Beck GR Jr, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A. 2000; 97(15): 8352-8357.
41. [41] Taguchi K, Okada A, Yasui T, Kobayashi T, Ando R, Tozawa K, Kohri K. Pioglitazone, a Peroxisome Proliferator Activated Receptor γ Agonist, Decreases Renal Crystal Deposition, Oxidative Stress and Inflammation in Hyperoxaluric Rats. J Urol. 2012; 188(3): 1002-1011. [CrossRef]
42. [42] Ilhan M, Ergene B, Süntar I, Ozbilgin S, Saltan Çitoğlu G, Demirel MA, Keleş H, Altun L, Küpeli Akkol E. Preclinical Evaluation of Antiurolithiatic Activity of Viburnum opulus L. on Sodium Oxalate-Induced Urolithiasis Rat Model. Evid Based Complement Alternat Med. 2014; Article ID: 578103. [CrossRef]
43. [43] Zeng X, Xi Y, Jiang W. Protective roles of flavonoids and flavonoid-rich plant extracts against urolithiasis. Crit Rev Food Sci Nutr. 2019; 59(13): 2125-2135. [CrossRef]
44. [44] Pinelli P, Ieri F, Vignolini P, Bacci L, Baronti S, Romani A. Extraction and HPLC Analysis of Phenolic Compounds in Leaves, Stalks, and Textile Fibers of Urtica dioica L. J Agric Food Chem. 2008; 56(19): 9127-32. [CrossRef]
45. [45] Zou YH, Liu WT, Zhang JX, Xiang DC. Triterpenoids from the bark of Dysoxylum hainanense and their anti-inflammatory and radical scavenging activity. Fitoterapia. 2017; 121: 159-163. [CrossRef]
46. [46] Phosrithong N, Nuchtavorn N. Antioxidant and anti-inflammatory activites of Clerodendrum leaf extracts collected in Thailand. Eur J Integr Med. 2016; 3: 281-285. [CrossRef]
47. [47] Yıldırım A, Şen A, Doğan A, Bitiş L. Antioxidant and anti-inflammatory activity of capitula, leaf and stem extracts of Tanacetum cilicicum (Boiss.) Grierson. International Journal of Secondary Metabolite. 2019; 6: 211-222. [CrossRef]
48. [48] Gao X, Ohlander M, Jeppsson N, Björk L, Trajkovski V. Changes in antioxidant effects and their relationship to phytonutrients in fruits of Sea Buckthorn (Hippophae rhamnoides L.) during maturation. Journal of Agricultural and Food Chemistry. 2000; 48,1485-1490. [CrossRef]
49. [49] Koca U, Olguner ÇG, Ergür BU, Altekin E, Taşdöğen A, Duru S, Girgin P, Gündüz K, Cilaker Mıcılı S, Güzeldağ S, Akkuş M. The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis. ScientificWorldJournal. 2013; 2013:292687. [CrossRef]